Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis.

Das S, Finney AC, Anand SK, Rohilla S, Liu Y, Pandey N, Ghrayeb A, Kumar D, Nunez K, Liu Z, Arias F, Zhao Y, Pearson-Gallion BH, McKinney MP, Richard KSE, Gomez-Vidal JA, Abdullah CS, Cockerham ED, Eniafe J, Yurochko AD, Magdy T, Pattillo CB, Kevil CG, Razani B, Bhuiyan MS, Seeley EH, Galliano GE, Wei B, Tan L, Mahmud I, Surakka I, Garcia-Barrio MT, Lorenzi PL, Gottlieb E, Salido E, Zhang J, Orr AW, Liu W, Diaz-Gavilan M, Chen YE, Dhanesha N, Thevenot PT, Cohen AJ, Yurdagul A Jr, Rom O

Open source

DOI: 10.1038/s42255-024-01134-4
Published: 2024 Oct
Container: Nature metabolism
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s42255-024-01134-4,
  title = {Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis.},
  author = {Das S and Finney AC and Anand SK and Rohilla S and Liu Y and Pandey N and Ghrayeb A and Kumar D and Nunez K and Liu Z and Arias F and Zhao Y and Pearson-Gallion BH and McKinney MP and Richard KSE and Gomez-Vidal JA and Abdullah CS and Cockerham ED and Eniafe J and Yurochko AD and Magdy T and Pattillo CB and Kevil CG and Razani B and Bhuiyan MS and Seeley EH and Galliano GE and Wei B and Tan L and Mahmud I and Surakka I and Garcia-Barrio MT and Lorenzi PL and Gottlieb E and Salido E and Zhang J and Orr AW and Liu W and Diaz-Gavilan M and Chen YE and Dhanesha N and Thevenot PT and Cohen AJ and Yurdagul A Jr and Rom O},
  year = {2024},
  journal = {Nature metabolism},
  doi = {10.1038/s42255-024-01134-4},
  url = {https://doi.org/10.1038/s42255-024-01134-4}
}

RIS

TY  - JOUR
TI  - Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis.
AU  - Das S
AU  - Finney AC
AU  - Anand SK
AU  - Rohilla S
AU  - Liu Y
AU  - Pandey N
AU  - Ghrayeb A
AU  - Kumar D
AU  - Nunez K
AU  - Liu Z
AU  - Arias F
AU  - Zhao Y
AU  - Pearson-Gallion BH
AU  - McKinney MP
AU  - Richard KSE
AU  - Gomez-Vidal JA
AU  - Abdullah CS
AU  - Cockerham ED
AU  - Eniafe J
AU  - Yurochko AD
AU  - Magdy T
AU  - Pattillo CB
AU  - Kevil CG
AU  - Razani B
AU  - Bhuiyan MS
AU  - Seeley EH
AU  - Galliano GE
AU  - Wei B
AU  - Tan L
AU  - Mahmud I
AU  - Surakka I
AU  - Garcia-Barrio MT
AU  - Lorenzi PL
AU  - Gottlieb E
AU  - Salido E
AU  - Zhang J
AU  - Orr AW
AU  - Liu W
AU  - Diaz-Gavilan M
AU  - Chen YE
AU  - Dhanesha N
AU  - Thevenot PT
AU  - Cohen AJ
AU  - Yurdagul A Jr
AU  - Rom O
PY  - 2024
JO  - Nature metabolism
DO  - 10.1038/s42255-024-01134-4
UR  - https://doi.org/10.1038/s42255-024-01134-4
ER  -

APA

S, D., AC, F., SK, A., S, R., Y, L., N, P., A, G., D, K., K, N., Z, L., F, A., Y, Z., BH, P., MP, M., KSE, R., JA, G., CS, A., ED, C., J, E., AD, Y., T, M., CB, P., CG, K., B, R., MS, B., EH, S., GE, G., B, W., L, T., I, M., I, S., MT, G., PL, L., E, G., E, S., J, Z., AW, O., W, L., M, D., YE, C., N, D., PT, T., AJ, C., Jr, Y. A., & O, R. (2024). Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis.. Nature metabolism. https://doi.org/10.1038/s42255-024-01134-4

Source records

pubmed · retrieved 2026-09-27T10:46:47.648Z